Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance

[1]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.

[2]  Chris Bailey-Kellogg,et al.  Protein deimmunization via structure‐based design enables efficient epitope deletion at high mutational loads , 2015, Biotechnology and bioengineering.

[3]  Chris Bailey-Kellogg,et al.  Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate , 2015, PLoS Comput. Biol..

[4]  H. Spits,et al.  Critical assessment of human antibody generation in humanized mouse models. , 2014, Journal of immunological methods.

[5]  Andrew S. Parker,et al.  Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate , 2014, Cellular and Molecular Life Sciences.

[6]  David Baker,et al.  Removing T-cell epitopes with computational protein design , 2014, Proceedings of the National Academy of Sciences.

[7]  D. Baker,et al.  Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes , 2014, Proceedings of the National Academy of Sciences.

[8]  Chris Bailey-Kellogg,et al.  A high throughput MHC II binding assay for quantitative analysis of peptide epitopes. , 2014, Journal of visualized experiments : JoVE.

[9]  Chris Bailey-Kellogg,et al.  Gene and Protein Sequence Optimization for High-Level Production of Fully Active and Aglycosylated Lysostaphin in Pichia pastoris , 2014, Applied and Environmental Microbiology.

[10]  Vibha Jawa,et al.  T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation. , 2013, Clinical immunology.

[11]  Raymond Schuch,et al.  Lysins: the arrival of pathogen-directed anti-infectives. , 2013, Journal of medical microbiology.

[12]  C M Macal,et al.  The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  M. Schmelcher,et al.  Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme. , 2013, FEMS microbiology letters.

[14]  David L. Smith,et al.  The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. , 2013, American journal of epidemiology.

[15]  Lorena Rodríguez-Rubio,et al.  Potential of the Virion-Associated Peptidoglycan Hydrolase HydH5 and Its Derivative Fusion Proteins in Milk Biopreservation , 2013, PloS one.

[16]  G. Guebitz,et al.  Antimicrobial enzymes: An emerging strategy to fight microbes and microbial biofilms , 2013, Biotechnology journal.

[17]  R. Kotłowski,et al.  Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus , 2012, Applied Microbiology and Biotechnology.

[18]  Chris Bailey-Kellogg,et al.  Design and analysis of immune-evading enzymes for ADEPT therapy. , 2012, Protein engineering, design & selection : PEDS.

[19]  Chris Bailey-Kellogg,et al.  Structure-Guided Deimmunization of Therapeutic Proteins , 2012, RECOMB.

[20]  J. Raj,et al.  Antistaphylococcal activity of bacteriophage derived chimeric protein P128 , 2012, BMC Microbiology.

[21]  Chris Bailey-Kellogg,et al.  A divide‐and‐conquer approach to determine the Pareto frontier for optimization of protein engineering experiments , 2012, Proteins.

[22]  George Georgiou,et al.  Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift , 2011, Proceedings of the National Academy of Sciences.

[23]  Marco Biasini,et al.  Toward the estimation of the absolute quality of individual protein structure models , 2010, Bioinform..

[24]  Chad W. Euler,et al.  A Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus Strains , 2010, Antimicrobial Agents and Chemotherapy.

[25]  Yoonjoo Choi,et al.  FREAD revisited: Accurate loop structure prediction using a database search algorithm , 2010, Proteins.

[26]  Chad W. Euler,et al.  Synergism between a Novel Chimeric Lysin and Oxacillin Protects against Infection by Methicillin-Resistant Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.

[27]  Paul D. R. Johnson,et al.  Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications , 2010, Clinical Microbiology Reviews.

[28]  D. Nathwani,et al.  MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia , 2009, European Respiratory Journal.

[29]  Roland L. Dunbrack,et al.  proteins STRUCTURE O FUNCTION O BIOINFORMATICS Improved prediction of protein side-chain conformations with SCWRL4 , 2022 .

[30]  A. Pantosti,et al.  What is MRSA? , 2009, European Respiratory Journal.

[31]  J. Cizeau,et al.  Engineering and Biological Characterization of VB6-845, an Anti-EpCAM Immunotoxin Containing a T-cell Epitope-depleted Variant of the Plant Toxin Bouganin , 2009, Journal of immunotherapy.

[32]  Mamoru Ito,et al.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). , 2009, International immunology.

[33]  Andrew D. Luster,et al.  Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice , 2009, Journal of Virology.

[34]  Amy C. Anderson,et al.  Computational structure-based redesign of enzyme activity , 2009, Proceedings of the National Academy of Sciences.

[35]  Gary Taubes,et al.  The Bacteria Fight Back , 2008, Science.

[36]  M. Sykes,et al.  Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. , 2008, Blood.

[37]  Anne S De Groot,et al.  Immunogenicity of protein therapeutics. , 2007, Trends in immunology.

[38]  F. Niesen,et al.  The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability , 2007, Nature Protocols.

[39]  T. Jones,et al.  Identification and removal of immunogenicity in therapeutic proteins. , 2007, Current opinion in drug discovery & development.

[40]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[41]  A. Sali,et al.  Statistical potential for assessment and prediction of protein structures , 2006, Protein science : a publication of the Protein Society.

[42]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[43]  S. Depil,et al.  Peptide-binding assays and HLA II transgenic Abeta degrees mice are consistent and complementary tools for identifying HLA II-restricted peptides. , 2006, Vaccine.

[44]  M. Bochtler,et al.  Crystal structures of active LytM. , 2005, Journal of molecular biology.

[45]  Wolfgang Aehle,et al.  A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy , 2005, Molecular Cancer Therapeutics.

[46]  Bruno Hoen,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, JAMA.

[47]  T. Baglin,et al.  Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII , 2005, Journal of thrombosis and haemostasis : JTH.

[48]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  S. Walsh,et al.  Improved Pharmacokinetics and Reduced Antibody Reactivity of Lysostaphin Conjugated to Polyethylene Glycol , 2003, Antimicrobial Agents and Chemotherapy.

[50]  A. Jevnikar,et al.  The relationship between predicted peptide–MHC class II affinity and T-cell activation in a HLA-DRβ1*0401 transgenic mouse model , 2002, Arthritis research & therapy.

[51]  John Sidney,et al.  The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity1 , 2002, The Journal of Immunology.

[52]  Molecular therapy , 2002, Journal of the Neurological Sciences.

[53]  Marc De Maeyer,et al.  Elimination of a Human T-cell Region in Staphylokinase by T-cell Screening and Computer Modeling , 2002, Thrombosis and Haemostasis.

[54]  A. D. De Groot,et al.  Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. , 1998, Vaccine.

[55]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[56]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[57]  F. Falcioni,et al.  HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis , 1996, The Journal of experimental medicine.

[58]  Peter A. Kollman,et al.  AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .

[59]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[60]  K. Griswold,et al.  Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. , 2015, FEMS microbiology letters.

[61]  J. Klumpp,et al.  Endolysins as antimicrobials. , 2012, Advances in virus research.

[62]  E. Mylonakis,et al.  Lysostaphin: a silver bullet for staph. , 2012 .

[63]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[64]  P Argos,et al.  Oligopeptide biases in protein sequences and their use in predicting protein coding regions in nucleotide sequences , 1988, Proteins.